FDA ad­vi­so­ry com­mit­tee votes unan­i­mous­ly in fa­vor of bi­va­lent Covid shots re­plac­ing pri­ma­ry se­ries

3 years ago
Pharma
FDA+

FDA re­ports ini­tial 'no sig­nal' for stroke risk with Pfiz­er boost­ers, launch­es con­comi­tant flu shot study

3 years ago
Pharma
FDA+

In a win for Re­gen­eron, No­var­tis' sy­ringe for AMD drug de­clared 'un­patentable'

3 years ago
Pharma
Law

'Tis the sea­son: GSK ad­dress­es win­ter virus surges with celebri­ty and in­flu­encer vac­cine aware­ness cam­paigns

3 years ago
Pharma
Marketing

Bris­tol My­ers claims win with CAR-T ther­a­py Breyanzi in leukemia

3 years ago
R&D
Pharma

FDA cuts off use for As­traZeneca’s Covid-19 ther­a­py Evusheld

3 years ago
Pharma
FDA+

FDA takes next step in Tor­rent Phar­ma­ceu­ti­cal­s' trou­bled In­dia plant saga, is­sues OAI

3 years ago
Pharma
FDA+

Man­u­fac­tur­ing roundup: AGC Bi­o­log­ics to man­u­fac­ture di­a­betes ther­a­py; Cam­brex caps ac­qui­si­tion of Snap­drag­on ...

3 years ago
Manufacturing

Evotec inks li­cense agree­ment with J&J; On­colyt­ic virus biotech prices $15M IPO

3 years ago
News Briefing

Proflu­ent de­buts to de­sign pro­teins with ma­chine learn­ing in bid to move past 'AI sprin­kled on top'

3 years ago
Financing
Startups

In­vestor 'misalign­men­t' leads to tR­NA biotech's shut­ter­ing

3 years ago
People
Startups

Aridis' mon­o­clon­al an­ti­body fails PhI­II, but plans for sec­ond tri­al any­way

3 years ago
R&D

Xy­lo­Cor wraps up PhII for heart dis­ease gene ther­a­py, plans for piv­otal tri­al

3 years ago
R&D
Cell/Gene Tx

Abzena lays off more than 60 em­ploy­ees in Cal­i­for­nia

3 years ago
People
Manufacturing

#JPM23: What's re­al­ly dri­ving the cost of health­care and drugs in 2023?

3 years ago

Oral drug for di­a­bet­ic retinopa­thy flunks PhII, but biotech wants to go in­to PhI­II with new end­point

3 years ago
R&D

Grey Wolf reels in $49M to en­ter the clin­ic for new im­munother­a­py tar­get

3 years ago
Financing
Startups

Pa­tient death spurs tri­al halt for Ma­gen­ta Ther­a­peu­tics

3 years ago
R&D

FDA sends warn­ing let­ter to com­mu­ni­ty hos­pi­tal re­view board over re­search con­cerns

3 years ago
Pharma
FDA+

Har­ris Poll breaks down #JPM23 con­fer­ence’s hottest top­ics and pop­u­lar peo­ple among in­dus­try ex­perts

3 years ago
Marketing

Mer­ck halts prostate can­cer study while re­port­ing pos­i­tive read­out in bil­iary tract can­cer

3 years ago
R&D
Pharma

Lon­za posts full 2022 re­sults as it looks to buy back $2B+ in shares

3 years ago
Pharma
Manufacturing

No­var­tis re-en­lists spokescelebri­ty Ken Jeong for Xi­idra movie trail­er spoof cam­paign

3 years ago
Pharma
Marketing

NIH as­so­ciate di­rec­tor an­nounces de­par­ture to pri­vate sec­tor, join­ing an­ti-ag­ing biotech

3 years ago
People
First page Previous page 396397398399400401402 Next page Last page
A service from the Financial Times